Svelte Medical starts trial of Stent-on-a-Wire
This article was originally published in Clinica
Svelte Medical Systems has started a European clinical trial of its Stent-on-a-Wire (SOAW) cobalt-chromium bare metal stent. The device is easy to deliver and could reduce the cost of procedures and potentially lower the rate of stent thromboses, New Providence, New Jersey-based Svelte claimed. It hopes to CE mark the first-generation SOAW for sale in Europe by the middle of this year, and start trials of a drug-eluting version in 2011. The latter will be non-inflammatory, as it will not use typical polymeric coatings which can irritate the blood vessel lining, Svelte says. The company also hopes to start clinical trials of the product in Brazil and Columbia during this quarter.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.